Health Care Costs
SEE-ACBT Method Improves Postsurgical Outcomes in Lung Cancer Resection
April 04, 2018In a quasi-experimental pre-post study, researchers demonstrate the efficacy of the SEE-ACBT rehabilitation method on health-related and cost outcomes in patients with NSCLC who underwent curative lung resection.
Improved Access to Care Reported by Cancer Survivors
April 04, 2018In the 2010 to 2016 period, the proportion of survivors reporting delayed medical care decreased yearly.
Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
February 28, 2018At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs. Yet ongoing studies seek to determine how this technology fits into current treatment regimens for prostate, breast, and other cancers.
Lower-Income Households Experienced Improved Health Costs After ACA Implementation
February 28, 2018The Affordable Care Act was linked to reduced cost burdens for middle to low-income households, study data indicate.
Pomalidomide Plus Dexamethasone Effective in R/R Multiple Myeloma
February 07, 2018Researchers report on their findings of a retrospective study that compared pomalidomide plus dexamethasone vs dexamethasone alone in patients with relapsed/refractory multiple myeloma.
Better Postoperative Outcomes With RAMIE for Esophageal Cancer
January 18, 2018Research presented at the 2018 Gastrointestinal Cancers Symposium described benefits seen with RAMIE vs chemotherapy or chemoradiotherapy plus OTE for esophageal cancer.
Ovarian Cancer Screening Potentially Cost-Effective in the United States
December 15, 2017Multimodal screening is more expensive, but reduces ovarian cancer mortality, researchers found.
Relapsed Ph-Negative Acute Lymphoblastic Leukemia Incurs a High Economic Burden
December 12, 2017Recent study findings investigated the economic burden of patients with relapsed Ph-negative ALL, and the adverse events of special interest that are most likely to have the greatest impact. These findings were presented at ASH 2017.
Physical Examination Sufficient Work-up for Complaints of Breast Pain
December 08, 2017A single-center analysis demonstrates likelihood that mastalgia indicates presence of breast cancer and extensiveness of common work-up for the complaint. These findings were presented at SABCS 2017.
Symptoms, Economic Burden Reduce QoL in Gastrointestinal Cancer Survivors
October 06, 2017A cross-sectional survey revealed the impact of symptoms and economic burden on quality of life for survivors of gastrointestinal cancer.
Surveillance Plus FIT for CRC Screening: Additional Costs Not Justified by Benefits
October 05, 2017Investigators sought to determine clinical and cost effectiveness of additional colonoscopy screening in patients undergoing FIT screening for colorectal cancer.
Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
September 25, 2017Development of carcinoid syndrome has a profound effect on cost of care for patients with neuroendocrine tumors (NETs).
Median Cost of Cancer Drug Development is Approximately $648 Million
September 12, 2017Total revenue from sales of 10 drugs was 67.0 billion, with total RD spending of 7.2 billion, researchers found.
Insured Patients with Cancer May Experience Financial Distress
August 11, 2017Cancer treatment is far costlier than expected, even for patients with cancer who have health insurance coverage, with being underinsured causing in the most distress for patients.
Poll: Many Seniors Struggling With Drug Costs Don't Seek Help
July 05, 2017Roughly half of older Americans experiencing difficulty paying for needed drugs did not talk to their physicians about the issue, poll shows.
Clinical Trials May Benefit Oncology Patients
June 22, 2017Research on the effects of research demonstrated that oncology-related clinical trials provide measurable benefits in terms
New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
June 21, 2017Doses May Be Adjusted for Treating NSCLC Patients
Can Biosimilars Help Achieve the Goals of US Health Care Reform?
June 16, 2017[Cancer Management and Research] This research examines the pros and cons of the Affordable Care Act enactment and the possible beneficial role biosimilars may play in this environment.
Young Cancer Survivors More Often Have Cost-Related Nonadherence
June 14, 2017Risk of nonadherence was lower for survivors reporting a usual source of care than those without
United States Leads in Income-Based Health Care Inequalities
June 12, 2017More public tolerance for health care inequalities has been observed in the United States than other countries.
Obesity Increases Costs Across Health Care Settings
June 05, 2017Percentage increases in costs associated with obesity were highest for medications, higher for women
Tai Chi Effective, Affordable Alternative to CBT-I for Insomnia in Breast Cancer Survivors
June 02, 2017Tai chi is as effective as cognitive behavioral therapy for insomnia (CBT-I) for the treatment of insomnia in breast cancer survivors.
Costs High for Myeloma Patients Not Getting Low-Income Subsidy
May 31, 2017For those aged 75 to 84 years, LIS receipt linked to increased odds of receiving immunomodulatory drugs
Proposed Health Care Act Could Result in 23 Million Losing Insurance
May 29, 2017Although premiums may lower over the long-term, many would face much higher out-of-pocket costs under the new plan.
Plan Suggests Ways for Reducing Health Care Costs
May 17, 2017Nine-point plan includes streamlining billing, reducing high facility fees, and reducing drug costs.
Many Americans Concerned About ACA Repeal
May 08, 2017Only twenty percent of Americans support repeal of the Affordable Care Act (ACA), but overall opinions differ by political affiliation.
Putting a Name on the Impact of Cancer Treatment Costs
May 02, 2017I hear the term "financial toxicity" used more and more when people are discussing the cost of cancer treatments. What exactly is financial toxicity?
Barriers in Routine Care Coverage for Cancer Clinical Trial Participants Still Exist
April 05, 2017Despite the ACA mandate on coverage for clinical trial participants, many facilities involved in cancer research still coping with insurance denials for participants.
Postoperative Outcomes Similar With Mobile App Follow-up for Ambulatory Breast Reconstruction
April 03, 2017Follow-up via mobile app similar to in-person postoperative visits for low-risk ambulatory patients after breast reconstruction.
Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations
March 28, 2017A free lung cancer screening program in Augusta, Georgia, found more than double the lung cancer rate of previous screenings.
Sign Up for Free e-newsletters
ONA Articles
- Redefining Prognosis for Hematologic Cancers in Older Adults by Age
- Progression-Free Survival Extended With PANEX Protocol in R/R Multiple Myeloma
- In Older Women With Breast Cancer QoL May Predict 10-Year Mortality
- Evolving Role of Radiation Therapy in the Treatment of Mesothelioma
- Elderly Patients Are Underrepresented in Trials For Soft Tissue Sarcoma
- Letter-Writing Project Communicates Care Wishes to Healthcare Team, Family
- Pivot Nurse Improves Patients' Navigation Through Lung Cancer Care
- Long-term Carfilzomib May Be Safe, Effective In Relapsed Multiple Myeloma
- Palliative Sedation a Valid Option for Refractory Symptoms in End-stage Cancer
- Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases
- Lenalidomide Alone or With Dexamethasone Effective in Relapsed Multiple Myeloma
- Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases
- Spotlight on Triptorelin in the Treatment of Premenopausal Women with Early-Stage Breast Cancer
- Redefining Prognosis for Hematologic Cancers in Older Adults by Age
- Outcomes for Elderly With Hematologic Cancers Effected by Cognitive Impairments
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |